Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma, Non-Small-Cell Lung × Data Collection × Clear all

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Papillomavirus Infections 7 Uterine Cervical Neoplasms 4 Neuroendocrine Tumors 4 Neoplasms 4 Autoimmune Diseases 3 Ovarian Neoplasms 2 Myasthenia Gravis 2 Mesothelioma, Malignant 2 Venous Thrombosis 1 Venous Thromboembolism 1 Thyroid Diseases 1 Thrombosis 1 Retinal Telangiectasis 1 Renal Insufficiency 1 Recurrence 1 Prostatic Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mesothelioma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphohistiocytosis, Hemophagocytic 1 Lung Neoplasms 1 Leukemia, Hairy Cell 1 Hemorrhage 1 Hematologic Neoplasms 1 Fanconi Anemia, Complementation Group D1 1 Desmoid Tumors 1 Cysts 1 Colonic Neoplasms 1

Interventions

Carboplatin 297 Paclitaxel 223 Cisplatin 201 Pemetrexed 200 Docetaxel 186 Erlotinib Hydrochloride 176 Gemcitabine 163 Bevacizumab 111 pembrolizumab 108 Radiotherapy 102 Nivolumab 73 Gefitinib 63 Vinorelbine 57 Cetuximab 50 atezolizumab 39 Afatinib 38 durvalumab 33 osimertinib 30 Drug Therapy 30 Radiosurgery 29 Albumin-Bound Paclitaxel 27 Ipilimumab 26 Surgical Procedures, Operative 25 130-nm albumin-bound paclitaxel 25 Taxes 24 Irinotecan 21 Etoposide 20 Magnetic Resonance Spectroscopy 19 Cyclophosphamide 19 Sorafenib 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01772225 2014-03-31

LuCaBIS

GlaxoSmithKline

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡